BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 29637495)

  • 1. High-throughput genetic screens using CRISPR-Cas9 system.
    Kweon J; Kim Y
    Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-throughput functional screening using CRISPR/Cas9 system].
    Wang GC; Ming M; Ye YZ; Xi JZ
    Yi Chuan; 2016 May; 38(5):391-401. PubMed ID: 27232487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying synthetic lethal targets using CRISPR/Cas9 system.
    Dhanjal JK; Radhakrishnan N; Sundar D
    Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target Discovery for Precision Medicine Using High-Throughput Genome Engineering.
    Guo X; Chitale P; Sanjana NE
    Adv Exp Med Biol; 2017; 1016():123-145. PubMed ID: 29130157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens.
    Winter J; Breinig M; Heigwer F; Brügemann D; Leible S; Pelz O; Zhan T; Boutros M
    Bioinformatics; 2016 Feb; 32(4):632-4. PubMed ID: 26508755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas-based customization of pooled CRISPR libraries.
    Kweon J; Kim DE; Jang AH; Kim Y
    PLoS One; 2018; 13(6):e0199473. PubMed ID: 29924860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
    Klann TS; Black JB; Chellappan M; Safi A; Song L; Hilton IB; Crawford GE; Reddy TE; Gersbach CA
    Nat Biotechnol; 2017 Jun; 35(6):561-568. PubMed ID: 28369033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation with CRISPR-Cas9: principles, advances, and applications.
    Didovyk A; Borek B; Tsimring L; Hasty J
    Curr Opin Biotechnol; 2016 Aug; 40():177-184. PubMed ID: 27344519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
    Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
    BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 for cancer research and therapy.
    Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
    Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional genetic screening using CRISPR-Cas9 system].
    Li H; Huang C
    Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):461-472. PubMed ID: 29701021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9-AID base editor is a powerful gain-of-function screening tool.
    Kuscu C; Adli M
    Nat Methods; 2016 Nov; 13(12):983-984. PubMed ID: 27898061
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovations in CRISPR technology.
    Brooks AK; Gaj T
    Curr Opin Biotechnol; 2018 Aug; 52():95-101. PubMed ID: 29626736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
    Prykhozhij SV; Caceres L; Berman JN
    Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.